102PD MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC): FROM PROOF-OF-CONCEPT TO PHASE III TRIAL (MAGRIT)

Lung Cancer ◽

10.1016/s0169-5002(09)70225-9 ◽

2009 ◽

Vol 64 ◽

pp. S45

Author(s):

B. Passlick ◽

J. Vansteenkiste ◽

M. Zielinski ◽

A. Linder ◽

J. Dahabreh ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell ◽

Phase Iii ◽

Proof Of Concept ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Specific Cancer ◽

Resected Stage ◽

Cancer Immunotherapeutic

Download Full-text

MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC): from proof-of-concept to phase III trial (MAGRIT)

Lung Cancer ◽

10.1016/s0169-5002(09)70030-3 ◽

2009 ◽

Vol 63 ◽

pp. S10

Author(s):

T. Eisen ◽

J. Vansteenkiste ◽

M. Zielinski ◽

A. Linder ◽

J. Dahabreh ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell ◽

Phase Iii ◽

Proof Of Concept ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Specific Cancer ◽

Resected Stage ◽

Cancer Immunotherapeutic

Download Full-text

Association of gene expression signature and clinical efficacy of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7501 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7501-7501 ◽

Cited By ~ 33

Author(s):

J. F. Vansteenkiste ◽

M. Zielinski ◽

I. J. Dahabreh ◽

A. Linder ◽

F. Lehmann ◽

...

Keyword(s):

Gene Expression ◽

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Gene Expression Signature ◽

Small Cell ◽

Small Cell Lung ◽

Specific Cancer ◽

Resected Stage ◽

Cancer Immunotherapeutic

Download Full-text

Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data

Journal of Oncology Practice ◽

10.1200/jop.1.2.37 ◽

2005 ◽

Vol 1 (2) ◽

pp. 37-42 ◽

Cited By ~ 2

Author(s):

M. R. Green ◽

M. Andrews ◽

R. Leff ◽

J. Willey ◽

C. Allegra ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Trial Data ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Treatment Plans

Download Full-text

DERMA phase III trial of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in patients with MAGE-A3-positive resected stage III melanoma.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps232 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS232-TPS232 ◽

Cited By ~ 9

Author(s):

J. M. Kirkwood ◽

B. Dreno ◽

A. Hauschild ◽

D. Schadendorf ◽

A. Testori ◽

...

Keyword(s):

Adjuvant Therapy ◽

Phase Iii ◽

Stage Iii ◽

Phase Iii Trial ◽

Specific Cancer ◽

Stage Iii Melanoma ◽

Resected Stage ◽

Cancer Immunotherapeutic

Download Full-text

Magrit, a Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of the Recmage-A3 + As15 Cancer Immunotherapeutic As Adjuvant Therapy in Patients with Resected Mage-A3-Positive Non-Small Cell Lung Cancer (Nsclc)

Annals of Oncology ◽

10.1093/annonc/mdu347.1 ◽

2014 ◽

Vol 25 ◽

pp. iv409 ◽

Cited By ~ 24

Author(s):

J.F. Vansteenkiste ◽

B. Cho ◽

T. Vanakesa ◽

T. De Pas ◽

M. Zielinski ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Study ◽

Cancer Immunotherapeutic

Download Full-text

9008 ORAL Randomized Phase III Trial of Adjuvant Chemotherapy With Gemcitabine Compared With Oral Tegafur-uracil (UFT) in Resected, Stage IB-llla Non-small Cell Lung Cancer (WJTOG 0101)

European Journal of Cancer ◽

10.1016/s0959-8049(11)72320-6 ◽

2011 ◽

Vol 47 ◽

pp. S594 ◽

Cited By ~ 1

Author(s):

T. Mitsudomi ◽

H. Tada ◽

Y. Ichinose ◽

K. Yokoi ◽

N. Katakami ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Stage Ib ◽

Resected Stage

Download Full-text

Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non[ndash ]small cell lung cancer

Seminars in Oncology ◽

10.1053/sonc.2001.24366 ◽

2001 ◽

Vol 28 (2D) ◽

pp. 7-10

Author(s):

Pasquale Comella

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Efficacy and safety results from AvaALL: an open-label, randomized phase III trial of standard of care (SOC) with or without continuous bevacizumab (Bev) treatment beyond progression (PD) in patients (pts) with advanced non-small-cell lung cancer (NSCLC) progressing after first-line Bev and chemotherapy (chemo)

Pneumologie ◽

10.1055/s-0037-1619221 ◽

2018 ◽

Vol 72 (S 01) ◽

pp. S39-S40

Author(s):

F Griesinger ◽

J Bennouna ◽

J de Castro Carpeno ◽

AM Dingemans ◽

F Grossi ◽

...

Keyword(s):

Lung Cancer ◽

Standard Of Care ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Phase Iii Trial ◽

Treatment Beyond Progression

Download Full-text

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)

BioDrugs ◽

10.1007/s40259-021-00489-4 ◽

2021 ◽

Author(s):

Konstantinos Syrigos ◽

Istvan Abert ◽

Zoran Andric ◽

Igor N Bondarenko ◽

Mikhail Dvorkin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial

Annals of Oncology ◽

10.1093/annonc/mdx716 ◽

2018 ◽

Vol 29 (2) ◽

pp. 398-404 ◽

Cited By ~ 29

Author(s):

L. Ek ◽

E. Gezelius ◽

B. Bergman ◽

P.O. Bendahl ◽

H. Anderson ◽

...

Keyword(s):

Lung Cancer ◽

Molecular Weight ◽

Small Cell Lung Cancer ◽

Low Molecular Weight Heparin ◽

Standard Treatment ◽

Small Cell ◽

Phase Iii ◽

Low Molecular Weight ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text